Correlation Between Keros Therapeutics and Uniqure NV
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Uniqure NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Uniqure NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Uniqure NV, you can compare the effects of market volatilities on Keros Therapeutics and Uniqure NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Uniqure NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Uniqure NV.
Diversification Opportunities for Keros Therapeutics and Uniqure NV
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Keros and Uniqure is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Uniqure NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniqure NV and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Uniqure NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniqure NV has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Uniqure NV go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Uniqure NV
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.49 times more return on investment than Uniqure NV. However, Keros Therapeutics is 2.05 times less risky than Uniqure NV. It trades about -0.09 of its potential returns per unit of risk. Uniqure NV is currently generating about -0.05 per unit of risk. If you would invest 6,073 in Keros Therapeutics on August 28, 2024 and sell it today you would lose (415.00) from holding Keros Therapeutics or give up 6.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Keros Therapeutics vs. Uniqure NV
Performance |
| Timeline |
| Keros Therapeutics |
| Uniqure NV |
Keros Therapeutics and Uniqure NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and Uniqure NV
The main advantage of trading using opposite Keros Therapeutics and Uniqure NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Uniqure NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniqure NV will offset losses from the drop in Uniqure NV's long position.| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
| Uniqure NV vs. Rocket Pharmaceuticals | Uniqure NV vs. Rhythm Pharmaceuticals | Uniqure NV vs. Solid Biosciences LLC | Uniqure NV vs. MeiraGTx Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |